| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.228 | 23.359 | 32.603 | 27.492 | 33.951 | 61.088 | 23.025 | 16.496 | 38.750 | 11.653 |
| Total Income - EUR | 21.236 | 23.904 | 32.827 | 27.532 | 34.065 | 61.089 | 23.025 | 16.504 | 38.750 | 11.653 |
| Total Expenses - EUR | 9.848 | 25.980 | 21.513 | 20.602 | 22.718 | 33.354 | 17.030 | 10.350 | 25.514 | 9.014 |
| Gross Profit/Loss - EUR | 11.389 | -2.076 | 11.314 | 6.930 | 11.347 | 27.735 | 5.995 | 6.154 | 13.236 | 2.639 |
| Net Profit/Loss - EUR | 10.751 | -2.793 | 10.329 | 6.104 | 10.326 | 26.057 | 5.304 | 5.659 | 10.698 | 1.690 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Chemosafe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 322 | 0 | 0 | 1.049 | 4.591 | 3.547 | 2.902 | 2.382 | 1.862 |
| Current Assets | 20.341 | 5.562 | 16.802 | 22.710 | 30.502 | 53.605 | 45.218 | 41.744 | 45.982 | 30.213 |
| Inventories | 8.758 | 267 | 1.459 | 1.471 | 1 | 479 | 622 | 371 | 0 | 169 |
| Receivables | 5.247 | 1.569 | 12.314 | 18.424 | 18.207 | 17.987 | 44.370 | 41.168 | 44.376 | 29.572 |
| Cash | 6.336 | 3.726 | 3.029 | 2.815 | 12.295 | 35.139 | 226 | 205 | 1.606 | 472 |
| Shareholders Funds | 2.437 | -2.740 | 7.636 | 13.600 | 23.662 | 49.271 | 35.289 | 28.891 | 30.404 | 13.830 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.904 | 8.625 | 9.167 | 9.110 | 7.889 | 8.925 | 13.476 | 15.755 | 17.961 | 18.244 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Chemosafe S.r.l.